Our results showed significantly increased expression levels of MUC5AC and MUC5B and massive goblet cell metaplasia in the airways of COPD rats, while ECC-BYF III had an obvious inhibitory effect on these changes. This evidence concerns the gene MUC5B and chronic obstructive pulmonary disease.